Cost over sight? Spark's blindness cure has the industry talking

Spark has priced its cure for a rare form of blindness at $425,000 per eye. But rather than the science or the cost, pharma is buzzing over the company's outcomes-based pricing model

from Most popular articles from Medical Marketing and Media http://ift.tt/2Ey89Wt